Seung-jung Park
Clinical trials sponsored by Seung-jung Park, explained in plain language.
-
Heart procedure combo studied for safety, but trial cut short
Disease control TerminatedThis study tested a hybrid approach that combines bypass surgery and stenting to treat multiple blocked heart arteries. Only 6 people took part before the study was stopped early. The goal was to see if the procedure is safe and effective in real-world settings.
Sponsor: Seung-Jung Park • Aim: Disease control
Last updated May 17, 2026 13:26 UTC
-
Heart stent study halted early: what it means for patients
Disease control TerminatedThis study aimed to see how safe and effective the BIOFREEDOM stent is for people with narrowed heart arteries in everyday medical practice. About 218 adults who received the stent were followed to track serious events like death, heart attack, or the need for another procedure. …
Sponsor: Seung-Jung Park • Aim: Disease control
Last updated May 17, 2026 13:25 UTC
-
Heart study halted: did FFR help tandem lesions?
Disease control TerminatedThis study looked at whether using a pressure wire (FFR) to decide which narrowings to stent improves outcomes for people with two or more blockages in the same heart artery. The trial planned to enroll 438 people but was stopped early. The main goal was to see if this approach r…
Sponsor: Seung-Jung Park • Aim: Disease control
Last updated May 14, 2026 12:06 UTC